Morrison Briggs
SEC-identified person · CIK 1654430 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Arvinas, INC. AVRN | Director | filed 2018 - 2026 |
| Crispr Therapeutics AG CRSP | Director | filed 2025 - 2026 |
| Werewolf Therapeutics, Inc. HOWL | Director | filed 2021 - 2025 |
| Sesen Bio, Inc. SESN | Director | filed 2023 - 2024 |
| Repare Therapeutics Inc. RPTX | Director | filed 2020 - 2024 |
| Syndax Pharmaceuticals Inc SNDX | Director · President, Head of R&D | filed 2016 - 2024 |
| Codiak Biosciences, Inc. CDAK | Director | filed 2020 - 2021 |
| Oncorus, Inc. ONCR | Director | filed 2020 - 2020 |
| Nextcure, Inc. NXTC | Director | filed 2019 - 2020 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.